Please check your internet connection and try again.
# Sinex (oxymetazoline)
## Overview
Oxymetazoline is a direct-acting sympathomimetic amine that acts as an alpha-adrenergic agonist. It causes vasoconstriction of the arterioles in the nasal mucosa, reducing nasal congestion.
## Primary Indications
* Temporary relief of nasal congestion due to the common cold, hay fever, or upper respiratory allergies.
* Sinus congestion and pressure.
## Adult Dosing
* **Nasal Spray/Drops:** 2 to 3 sprays or drops in each nostril every 10 to 12 hours.
* **Maximum:** Do not exceed 2 doses within any 24-hour period.
* **Duration:** Limit use to **3 consecutive days** to prevent rebound congestion (*rhinitis medicamentosa*).
## Pediatric Dosing
* **Children 6 to 12 years:** 2 to 3 sprays of the 0.025% (pediatric) formulation in each nostril every 10 to 12 hours. Maximum: 2 doses in 24 hours.
* **Children under 6 years:** Use is not recommended unless directed by a pediatrician.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific dosage adjustments established; use with caution in patients with underlying systemic hypertension or cardiovascular disease.
## Contraindications
* Hypersensitivity to oxymetazoline or any component of the formulation.
* Avoid use if currently taking or within 14 days of discontinuing monoamine oxidase inhibitors (MAOIs).
## Adverse Effects
* **Common:** Local stinging, burning, sneezing, or increased nasal discharge.
* **Systemic (with overuse):** Hypertension, tachycardia, palpitations, headache, dizziness, nervousness, and insomnia.
* **Chronic Use:** *Rhinitis medicamentosa* (rebound congestion) causing a cycle of dependency.
## Key Drug Interactions
* **MAOIs:** Risk of hypertensive crisis.
* **Tricyclic Antidepressants (TCAs) / Maprotiline:** May potentiate the pressor effects of oxymetazoline.
* **Beta-Blockers:** Potential for increased blood pressure or bradycardia due to unopposed alpha-adrenergic stimulation.
## Monitoring
* Monitor for symptom duration. If congestion persists beyond 3 days, discontinue use and evaluate for underlying pathology.
* Assess blood pressure and heart rate in patients with known cardiovascular comorbidities.
## Clinical Pearls
* **Rhinitis Medicamentosa:** This is the most critical clinical concern. Patients should be warned that using the spray longer than 3 days can cause the congestion to become worse, leading them to use the drug more frequently.
* **Technique:** Instruct patients to sniff gently while spraying and to avoid sharing the bottle to prevent cross-contamination.
* **Systemic Absorption:** While considered local, systemic absorption can occur, especially if the nasal mucosa is irritated or if doses are exceeded.
***
**Educational Disclaimer:** This information is for educational purposes only. Drug dosing, availability, and labeling may vary by region. Always verify current prescribing information, package inserts, and local institutional protocols before administering or recommending medication.
